3
Announcements
Trials
Browse
Landscape
Phase
Phase 3
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Plasma cell
1
Other hematologic neoplasm
1
Lymphoid
1
Conditions
Ventricular Dysfunction
1
Precursor Cell Lymphoblastic Leukemia-Lymphoma
1
Neoplasms
1
Neoplasm Metastasis
1
Multiple Myeloma
1
Lymphoma, Non-Hodgkin
1
Lymphoma
1
Leukemia, Myeloid, Acute
1
Hypertension
1
Essential Hypertension
1
Cardiotoxicity
1
Breast Neoplasms
1
Interventions
Cytarabine
89
Daunorubicin
45
Azacitidine
43
Idarubicin
27
venetoclax
26
fludarabine
26
Etoposide
25
Cyclophosphamide
25
Mitoxantrone
22
Decitabine
19
Busulfan
19
Methotrexate
16
Gemtuzumab
14
Granulocyte Colony-Stimulating Factor
12
Whole-Body Irradiation
10
Peripheral Blood Stem Cell Transplantation
10
Melphalan
10
gilteritinib
9
Filgrastim
9
fludarabine phosphate
8
Tacrolimus
8
Mycophenolic Acid
8
Cyclosporine
8
Tretinoin
7
Radiotherapy
7
Drug Therapy
7
Observation
6
Homoharringtonine
6
Antilymphocyte Serum
6
quizartinib
5
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Phase 3
×
Leukemia, Myeloid, Acute
×
Enalapril
×
Clear all
NCT01110824
2013-11-15
OVERCOME
Hospital Clinic of Barcelona
Phase 3
Completed
90 enrolled